Immune Response to Hepatitis C Virus

Sponsored by Emory University

Phase Quota
Phase 1

The purpose of the study is to investigate the immune response to hepatitis C virus to determine why some people clear the virus and others develop chronic infection. Changes in immune response once hepatitis C therapy is begun will also be examined. If patients are also HIV+, the effect of antiretroviral therapy on the recovery of hepatitis C immunity will be investigated.

Study Start Date: September 2005

Estimated Completion Date: September 2005

Specialties: Internal Medicine: Infectious Disease Nursing: Immuno/Infectious Dz Infectious Disease: HIV/Immunodeficiency,Hepatitis,Other Viral/Bacterial Physician Assistant: Infectious Disease


  • Other: None. Not a clinical trial. Specimens taken for basic research in laboratory.

Inclusion criteria

  • Age >18 years with prior or active hepatitis C infection
  • HIV negative or HIV positive

Exclusion criteria

  • None

Study Locations And Contact Information

Feature this Clinical Trial

Get your trial in front of 1000s of physicians and patients.
Visit to find out how you can feature this clinical trial.